D Fairman, H Tang - The AAPS Journal, 2023 - Springer
Biologics, especially monoclonal antibodies (mAbs), are an increasingly important part of the drug discovery and development portfolio across the pharmaceutical industry. To enable …
J Berkhout, D Fairman, M van Noort… - CPT …, 2025 - Wiley Online Library
Integrated modeling of the pharmacokinetic (PK) and target binding, by means of a TMDD model, can provide valuable insights into the expected pharmacodynamic (PD) effects of …